Stock C1P CONSUN PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Consun Pharmaceutical Group Limited Deutsche Boerse AG

Equities

C1P

KYG2524A1031

Delayed Deutsche Boerse AG
Other stock markets
 02:05:34 2024-06-05 EDT 		5-day change 1st Jan Change
0.85 EUR +3.03% Intraday chart for Consun Pharmaceutical Group Limited +31.78% +60.38%
05-31 Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2023 CI
05-24 Consun Pharmaceutical Group Limited Announces Special Dividend, Payable on 21 June 2024 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2023
Consun Pharmaceutical Group Limited Announces Special Dividend, Payable on 21 June 2024
Consun Pharmaceutical Group Announces Special Dividend on 10th Anniversary of Joining HK Bourse
Consun Pharmaceutical to Grant About 8.2 Million Share Options Under New Program
Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on or About 21 June 2024
Consun Pharmaceutical Group Sees 15% Increase in 2023 Profit
Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024
Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Consun Pharmaceutical Group Limited Announces Board and Committee Changes
Consun Pharma CEO Steps Down
Consun Pharmaceutical Group Limited Announces CEO Changes
Consun Pharmaceutical Group Limited Announces Management Changes
Consun Pharmaceutical's Unit Starts Construction of Second Chinese Medicine Granule Plant
Consun Pharmaceutical's H1 Profit Rises on Higher Revenue
Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 20 September 2023
Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2022
Consun Pharmaceutical Group Limited Declares Final Dividend for the Year Ended December 31, 2022
Chinese Regulator Approves Consun Pharmaceutical's Clinical Trial for Kidney Disease Treatment
Consun Pharmaceutical Group Limited Receives Approval for Clinical Trial of Drug for SK-07 Injection
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1681 Stock
  4. C1P Stock
  5. News Consun Pharmaceutical Group Limited
  6. Other languages